Hongbo Lu, Director at Terns Pharmaceuticals, Inc. (TERN), bought 758,620 shares at $7.25 ($5.5M) on 2022-12-23, disclosed to the SEC on 2022-12-23.
Open-market purchase of $5.5M TERN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| ZBIO | BUY | 2026-03-31 | $1.5M | — | Filing → |
| ZBIO | BUY | 2026-02-13 | $585K | — | Filing → |
| ZBIO | BUY | 2025-10-09 | $5.0M | — | Filing → |